The Prokaryotic Expression of Cyclin-Dependent Kinase 2, and the Establish of Its Inhibitor Screening System

被引：0
|
作者：
Yuan, Yuan [1 ]
Gao, Meile [1 ]
Liu, Huan [1 ]
Ruan, Tingting [1 ]
Xie, Weiran [1 ]
Wu, Meng [1 ]
Qu, Xin [1 ]
Liu, Zhen [1 ]
Yu, Peng [1 ]
Teng, Yuou [1 ]
机构：
[1] Tianjin Univ Sci & Technol, Coll Biotechnol, Sinofrench Joint Lab Food Nutr Safety & Med Chem, Key Lab Ind Fermentat Microbiol,Tianjin Key Lab I, 29,13th St, Tianjin 300457, Peoples R China
来源：
ADVANCES IN APPLIED BIOTECHNOLOGY | 2018年 / 444卷
基金：
对外科技合作项目（国际科技项目）; 中国国家自然科学基金;
关键词：
CELL-CYCLE; PROTEIN-KINASE; MOLECULES; CANCER; CDKS;
D O I：
10.1007/978-981-10-4801-2_13
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：125 / 132
页数：8
相关论文
共 50 条
  • [31] Biochemical and cellular effects of a novel cyclin-dependent kinase inhibitor
    Jorda, R.
    Krystof, V.
    Havlicek, L.
    Strnad, M.
    EJC SUPPLEMENTS, 2008, 6 (09): : 84 - 84
  • [32] Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol
    Shapiro, GI
    CLINICAL CANCER RESEARCH, 2004, 10 (12) : 4270S - 4275S
  • [33] Cyclin-dependent kinase inhibitor gene polymorphisms in pituitary gigantism
    Run Yu
    Vivien Bonert
    Martha Cruz-Soto
    Shlomo Melmed
    Endocrine, 2006, 29 : 119 - 120
  • [34] Flavopiridol: a promising cyclin-dependent kinase inhibitor in cancer treatment
    Baghel, Uttam Singh
    Kriplani, Priyanka
    Patel, Neelam M.
    Kaur, Manpreet
    Sharma, Kapil
    Meghani, Monika
    Sharma, Abhay
    Singh, Deeksha
    Singh, Bhawani
    Setzer, William N.
    Sharifi-Rad, Javad
    Calina, Daniela
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024,
  • [35] Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor
    Gebbia, Vittorio
    Valerio, Maria Rosaria
    Firenze, Alberto
    Vigneri, Paolo
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (08) : 945 - 953
  • [36] Cyclin-dependent kinase inhibitor-related skin reactions
    Reactions Weekly, 2021, 1855 (1) : 11 - 11
  • [37] Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development
    Zhai, SP
    Senderowicz, AM
    Sausville, EA
    Figg, WD
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (05) : 905 - 911
  • [38] Cyclin-dependent kinase inhibitor gene polymorphisms in pituitary gigantism
    Yu, R
    Bonert, V
    Cruz-Soto, M
    Melmed, S
    ENDOCRINE, 2006, 29 (01) : 119 - 120
  • [39] Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas - Prognostic implications
    Erlanson, M
    Portin, C
    Linderholm, B
    Lindh, J
    Roos, G
    Landberg, G
    BLOOD, 1998, 92 (03) : 770 - 777
  • [40] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Gitig, DM
    Koff, A
    MOLECULAR BIOTECHNOLOGY, 2001, 19 (02) : 179 - 188
12345